Therapeutics: Receptor-like tyrosine kinase (RYK)

Neurology

INDICATION: Spinal cord injury (SCI)

Rat and mouse studies suggest inhibiting

Read the full 119 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE